Does magnesium support blood pressure and blood sugar?

What the evidence shows

The evidence combines different questions: dietary intake and future disease risk, supplementation and short-term biomarkers, and subgroup response by baseline magnesium or diabetes status. Those results must be reported separately rather than merged into one broad metabolic claim.^{[1], [2], [3]}

Blood-pressure trials found small average changes

A meta-analysis of 34 randomized, double-blind, placebo-controlled trials involving 2,028 adults reported average reductions of roughly 2 mm Hg in systolic pressure and 1.8 mm Hg in diastolic pressure. The median studied amount was about 368 mg per day for a median of three months.^{[1], [2]}

A separate analysis in adults with and without type 2 diabetes reported a similarly small systolic reduction, with a stronger signal in some diabetic participants who had low magnesium status.^{[1], [2]}

Subgroup findings do not predict every response

Some pooled analyses reported larger changes in participants with hypertension, diabetes, or low magnesium status than in broader populations. These subgroup patterns are useful for interpretation but do not establish that every person in a diagnostic category is deficient or will respond.^{[1], [2]}

Serum magnesium is commonly measured but has limited correlation with total-body or tissue magnesium. One isolated laboratory value cannot fully resolve status or predict a supplement effect.^{[4], [5]}

Higher dietary intake was associated with lower diabetes risk

A meta-analysis of 13 prospective cohorts included more than 536,000 participants and about 24,500 incident cases of type 2 diabetes. Higher dietary magnesium intake was associated with lower diabetes risk.^[3]

The dose-response analysis also reported a lower relative risk with each additional 100 mg per day of dietary magnesium. Because the source studies were observational, residual confounding and healthier dietary patterns may contribute to the association.^[3]

Supplementation produced a modest glucose signal

A meta-analysis of randomized trials in adults with and without diabetes reported an average improvement in fasting plasma glucose of about 4.6 mg/dL versus control. The pooled effect was modest and varied across populations and protocols.^[2]

A fasting-glucose result is not interchangeable with HbA1c, insulin resistance, diabetes prevention, or long-term complications. Each endpoint reflects a different biological and clinical question.^[2]

Amounts and durations describe the trials

Blood-pressure trials commonly used elemental-magnesium amounts in the few-hundred-milligram range for several weeks to months. Glucose studies used varied formulations, amounts, and durations.^{[1], [2]}

These protocol details help explain the evidence but do not identify one optimal personal amount. The pooled analyses reported heterogeneity and called for larger, better-designed trials.^{[1], [2]}

Biomarker changes are not treatment equivalence

A small average change in blood pressure or fasting glucose does not establish prevention of cardiovascular or diabetes complications. It also does not demonstrate equivalence to treatments supported by larger and longer outcome trials.^{[1], [2]}

The most defensible interpretation is that magnesium may modestly affect selected cardiometabolic markers in some populations, with substantial uncertainty about individual response and long-term clinical significance.^{[1], [2]}

Important limitations

The evidence combines short supplementation trials with observational dietary cohorts. Average effects were small, heterogeneity was meaningful, and subgroup findings do not predict an individual response. The studies do not establish a personal dose, treatment equivalence, or prevention of long-term complications.^{[1], [2], [3]}

Questions covered by the supporting research

These related questions are addressed in the cited evidence summaries and linked pages.

• How large were the average blood-pressure changes?
• Does higher dietary intake prove magnesium prevents diabetes?
• Were effects stronger in people with low magnesium status?
• Do the studies establish long-term clinical benefit?

Read the supporting evidence summaries

The linked research pages provide study populations, formulations, doses, outcomes, and limitations in greater detail.

• Magnesium and Blood Pressure →
• Magnesium and Blood Sugar →
• Signs of Magnesium Deficiency →

Related questions

• What does magnesium do in the body?
• What are signs of magnesium deficiency?
• How do different forms of magnesium differ?